nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—CYP3A4—prostate cancer	0.175	1	CbGaD
Acetazolamide—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0619	0.178	CbGbCtD
Acetazolamide—SLC22A6—Conjugated Estrogens—prostate cancer	0.0477	0.138	CbGbCtD
Acetazolamide—CYP3A4—Bicalutamide—prostate cancer	0.0325	0.0937	CbGbCtD
Acetazolamide—CYP3A4—Estramustine—prostate cancer	0.0302	0.0871	CbGbCtD
Acetazolamide—CYP3A4—Abiraterone—prostate cancer	0.0269	0.0776	CbGbCtD
Acetazolamide—CYP3A4—Flutamide—prostate cancer	0.0269	0.0776	CbGbCtD
Acetazolamide—CYP3A4—Cabazitaxel—prostate cancer	0.0199	0.0574	CbGbCtD
Acetazolamide—CYP3A4—Estrone—prostate cancer	0.0195	0.0561	CbGbCtD
Acetazolamide—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0174	0.05	CbGbCtD
Acetazolamide—AQP1—urine—prostate cancer	0.0165	0.163	CbGeAlD
Acetazolamide—CYP3A4—Conjugated Estrogens—prostate cancer	0.0127	0.0367	CbGbCtD
Acetazolamide—CYP3A4—Mitoxantrone—prostate cancer	0.0116	0.0334	CbGbCtD
Acetazolamide—CYP3A4—Estradiol—prostate cancer	0.0112	0.0322	CbGbCtD
Acetazolamide—CYP3A4—Prednisone—prostate cancer	0.00962	0.0277	CbGbCtD
Acetazolamide—CYP3A4—Etoposide—prostate cancer	0.00731	0.021	CbGbCtD
Acetazolamide—CYP3A4—Docetaxel—prostate cancer	0.00669	0.0193	CbGbCtD
Acetazolamide—AQP1—prostate gland—prostate cancer	0.00591	0.0585	CbGeAlD
Acetazolamide—AQP1—seminal vesicle—prostate cancer	0.005	0.0495	CbGeAlD
Acetazolamide—CYP3A4—Doxorubicin—prostate cancer	0.00498	0.0144	CbGbCtD
Acetazolamide—AQP1—epithelium—prostate cancer	0.00434	0.043	CbGeAlD
Acetazolamide—CA3—prostate gland—prostate cancer	0.00434	0.0429	CbGeAlD
Acetazolamide—AQP1—renal system—prostate cancer	0.00403	0.0399	CbGeAlD
Acetazolamide—AQP1—urethra—prostate cancer	0.00396	0.0392	CbGeAlD
Acetazolamide—CA14—prostate gland—prostate cancer	0.00394	0.0389	CbGeAlD
Acetazolamide—CA14—seminal vesicle—prostate cancer	0.00333	0.0329	CbGeAlD
Acetazolamide—CA7—renal system—prostate cancer	0.00322	0.0319	CbGeAlD
Acetazolamide—AQP1—bone marrow—prostate cancer	0.00305	0.0301	CbGeAlD
Acetazolamide—CYP3A4—urine—prostate cancer	0.00283	0.028	CbGeAlD
Acetazolamide—CA5B—prostate gland—prostate cancer	0.00275	0.0272	CbGeAlD
Acetazolamide—AQP1—testis—prostate cancer	0.0026	0.0258	CbGeAlD
Acetazolamide—CA3—bone marrow—prostate cancer	0.00223	0.0221	CbGeAlD
Acetazolamide—CA12—renal system—prostate cancer	0.00209	0.0207	CbGeAlD
Acetazolamide—Methazolamide—CYP2E1—prostate cancer	0.00202	0.382	CrCbGaD
Acetazolamide—Methazolamide—CYP2C19—prostate cancer	0.002	0.378	CrCbGaD
Acetazolamide—CA3—testis—prostate cancer	0.00191	0.0189	CbGeAlD
Acetazolamide—CA4—prostate gland—prostate cancer	0.0019	0.0188	CbGeAlD
Acetazolamide—AQP1—lymph node—prostate cancer	0.00189	0.0187	CbGeAlD
Acetazolamide—CA5B—urethra—prostate cancer	0.00184	0.0182	CbGeAlD
Acetazolamide—CA9—testis—prostate cancer	0.00183	0.0181	CbGeAlD
Acetazolamide—CA1—renal system—prostate cancer	0.00166	0.0164	CbGeAlD
Acetazolamide—CA4—seminal vesicle—prostate cancer	0.00161	0.0159	CbGeAlD
Acetazolamide—CA2—prostate gland—prostate cancer	0.00158	0.0156	CbGeAlD
Acetazolamide—CA3—lymph node—prostate cancer	0.00138	0.0137	CbGeAlD
Acetazolamide—CA2—seminal vesicle—prostate cancer	0.00133	0.0132	CbGeAlD
Acetazolamide—CA4—renal system—prostate cancer	0.0013	0.0128	CbGeAlD
Acetazolamide—CA4—urethra—prostate cancer	0.00127	0.0126	CbGeAlD
Acetazolamide—Methazolamide—CYP3A4—prostate cancer	0.00127	0.24	CrCbGaD
Acetazolamide—CA1—bone marrow—prostate cancer	0.00125	0.0124	CbGeAlD
Acetazolamide—CA5B—testis—prostate cancer	0.00121	0.012	CbGeAlD
Acetazolamide—CA2—epithelium—prostate cancer	0.00116	0.0115	CbGeAlD
Acetazolamide—CA2—renal system—prostate cancer	0.00107	0.0106	CbGeAlD
Acetazolamide—CA4—bone marrow—prostate cancer	0.00098	0.00969	CbGeAlD
Acetazolamide—CA5B—lymph node—prostate cancer	0.00088	0.0087	CbGeAlD
Acetazolamide—CA4—testis—prostate cancer	0.000838	0.00829	CbGeAlD
Acetazolamide—CA2—bone marrow—prostate cancer	0.000812	0.00804	CbGeAlD
Acetazolamide—CA1—lymph node—prostate cancer	0.000777	0.00768	CbGeAlD
Acetazolamide—CA2—testis—prostate cancer	0.000695	0.00687	CbGeAlD
Acetazolamide—CYP3A4—renal system—prostate cancer	0.000693	0.00686	CbGeAlD
Acetazolamide—CA4—lymph node—prostate cancer	0.000607	0.00601	CbGeAlD
Acetazolamide—CA2—lymph node—prostate cancer	0.000503	0.00498	CbGeAlD
Acetazolamide—Dizziness—Ethinyl Estradiol—prostate cancer	0.000286	0.00132	CcSEcCtD
Acetazolamide—Flushing—Etoposide—prostate cancer	0.000286	0.00132	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Epirubicin—prostate cancer	0.000286	0.00132	CcSEcCtD
Acetazolamide—Confusional state—Estradiol—prostate cancer	0.000285	0.00131	CcSEcCtD
Acetazolamide—Photosensitivity—Epirubicin—prostate cancer	0.000285	0.00131	CcSEcCtD
Acetazolamide—Urticaria—Goserelin—prostate cancer	0.000283	0.0013	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Docetaxel—prostate cancer	0.000283	0.0013	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Capecitabine—prostate cancer	0.000283	0.0013	CcSEcCtD
Acetazolamide—Anaphylactic shock—Estradiol—prostate cancer	0.000283	0.0013	CcSEcCtD
Acetazolamide—Body temperature increased—Goserelin—prostate cancer	0.000282	0.0013	CcSEcCtD
Acetazolamide—Urticaria—Conjugated Estrogens—prostate cancer	0.000281	0.00129	CcSEcCtD
Acetazolamide—Convulsion—Mitoxantrone—prostate cancer	0.00028	0.00129	CcSEcCtD
Acetazolamide—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000279	0.00128	CcSEcCtD
Acetazolamide—Shock—Estradiol—prostate cancer	0.000278	0.00128	CcSEcCtD
Acetazolamide—Hepatic failure—Epirubicin—prostate cancer	0.000278	0.00128	CcSEcCtD
Acetazolamide—Vomiting—Ethinyl Estradiol—prostate cancer	0.000275	0.00127	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Capecitabine—prostate cancer	0.000274	0.00126	CcSEcCtD
Acetazolamide—Discomfort—Mitoxantrone—prostate cancer	0.000271	0.00125	CcSEcCtD
Acetazolamide—Headache—Ethinyl Estradiol—prostate cancer	0.000271	0.00125	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Docetaxel—prostate cancer	0.00027	0.00124	CcSEcCtD
Acetazolamide—Agranulocytosis—Docetaxel—prostate cancer	0.000266	0.00123	CcSEcCtD
Acetazolamide—Confusional state—Mitoxantrone—prostate cancer	0.000266	0.00122	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Doxorubicin—prostate cancer	0.000265	0.00122	CcSEcCtD
Acetazolamide—Haematuria—Capecitabine—prostate cancer	0.000264	0.00121	CcSEcCtD
Acetazolamide—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000263	0.00121	CcSEcCtD
Acetazolamide—Photosensitivity—Doxorubicin—prostate cancer	0.000263	0.00121	CcSEcCtD
Acetazolamide—Dysgeusia—Etoposide—prostate cancer	0.000263	0.00121	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Capecitabine—prostate cancer	0.000261	0.0012	CcSEcCtD
Acetazolamide—Shock—Mitoxantrone—prostate cancer	0.000259	0.00119	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Epirubicin—prostate cancer	0.000258	0.00119	CcSEcCtD
Acetazolamide—Agranulocytosis—Capecitabine—prostate cancer	0.000258	0.00119	CcSEcCtD
Acetazolamide—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000258	0.00119	CcSEcCtD
Acetazolamide—Nausea—Ethinyl Estradiol—prostate cancer	0.000257	0.00118	CcSEcCtD
Acetazolamide—Hepatic failure—Doxorubicin—prostate cancer	0.000257	0.00118	CcSEcCtD
Acetazolamide—Hypoglycaemia—Epirubicin—prostate cancer	0.000256	0.00118	CcSEcCtD
Acetazolamide—Asthenia—Goserelin—prostate cancer	0.000256	0.00118	CcSEcCtD
Acetazolamide—Hypoaesthesia—Docetaxel—prostate cancer	0.000255	0.00117	CcSEcCtD
Acetazolamide—Paraesthesia—Estradiol—prostate cancer	0.000254	0.00117	CcSEcCtD
Acetazolamide—Asthenia—Conjugated Estrogens—prostate cancer	0.000253	0.00117	CcSEcCtD
Acetazolamide—Somnolence—Estradiol—prostate cancer	0.000251	0.00116	CcSEcCtD
Acetazolamide—Hyponatraemia—Epirubicin—prostate cancer	0.000251	0.00115	CcSEcCtD
Acetazolamide—Ill-defined disorder—Etoposide—prostate cancer	0.000249	0.00115	CcSEcCtD
Acetazolamide—Dyspepsia—Estradiol—prostate cancer	0.000249	0.00115	CcSEcCtD
Acetazolamide—Hypoaesthesia—Capecitabine—prostate cancer	0.000247	0.00114	CcSEcCtD
Acetazolamide—Decreased appetite—Estradiol—prostate cancer	0.000246	0.00113	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Estradiol—prostate cancer	0.000244	0.00112	CcSEcCtD
Acetazolamide—Diarrhoea—Goserelin—prostate cancer	0.000244	0.00112	CcSEcCtD
Acetazolamide—Fatigue—Estradiol—prostate cancer	0.000244	0.00112	CcSEcCtD
Acetazolamide—Erythema multiforme—Docetaxel—prostate cancer	0.000242	0.00112	CcSEcCtD
Acetazolamide—Malaise—Etoposide—prostate cancer	0.000242	0.00111	CcSEcCtD
Acetazolamide—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000242	0.00111	CcSEcCtD
Acetazolamide—Leukopenia—Etoposide—prostate cancer	0.00024	0.00111	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Doxorubicin—prostate cancer	0.000239	0.0011	CcSEcCtD
Acetazolamide—Flushing—Docetaxel—prostate cancer	0.000238	0.00109	CcSEcCtD
Acetazolamide—Hypoglycaemia—Doxorubicin—prostate cancer	0.000237	0.00109	CcSEcCtD
Acetazolamide—Paraesthesia—Mitoxantrone—prostate cancer	0.000236	0.00109	CcSEcCtD
Acetazolamide—Dizziness—Goserelin—prostate cancer	0.000236	0.00109	CcSEcCtD
Acetazolamide—Ataxia—Epirubicin—prostate cancer	0.000235	0.00108	CcSEcCtD
Acetazolamide—Erythema multiforme—Capecitabine—prostate cancer	0.000235	0.00108	CcSEcCtD
Acetazolamide—Somnolence—Mitoxantrone—prostate cancer	0.000234	0.00108	CcSEcCtD
Acetazolamide—Dizziness—Conjugated Estrogens—prostate cancer	0.000234	0.00107	CcSEcCtD
Acetazolamide—Feeling abnormal—Estradiol—prostate cancer	0.000233	0.00107	CcSEcCtD
Acetazolamide—Convulsion—Etoposide—prostate cancer	0.000233	0.00107	CcSEcCtD
Acetazolamide—Hyponatraemia—Doxorubicin—prostate cancer	0.000232	0.00107	CcSEcCtD
Acetazolamide—Dyspepsia—Mitoxantrone—prostate cancer	0.000232	0.00107	CcSEcCtD
Acetazolamide—Tinnitus—Capecitabine—prostate cancer	0.000231	0.00106	CcSEcCtD
Acetazolamide—Flushing—Capecitabine—prostate cancer	0.00023	0.00106	CcSEcCtD
Acetazolamide—Decreased appetite—Mitoxantrone—prostate cancer	0.000229	0.00105	CcSEcCtD
Acetazolamide—Hypokalaemia—Epirubicin—prostate cancer	0.000227	0.00105	CcSEcCtD
Acetazolamide—Fatigue—Mitoxantrone—prostate cancer	0.000227	0.00105	CcSEcCtD
Acetazolamide—Vomiting—Goserelin—prostate cancer	0.000227	0.00104	CcSEcCtD
Acetazolamide—Discomfort—Etoposide—prostate cancer	0.000226	0.00104	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Epirubicin—prostate cancer	0.000225	0.00104	CcSEcCtD
Acetazolamide—Vomiting—Conjugated Estrogens—prostate cancer	0.000225	0.00103	CcSEcCtD
Acetazolamide—Urticaria—Estradiol—prostate cancer	0.000225	0.00103	CcSEcCtD
Acetazolamide—Body temperature increased—Estradiol—prostate cancer	0.000223	0.00103	CcSEcCtD
Acetazolamide—Headache—Goserelin—prostate cancer	0.000223	0.00103	CcSEcCtD
Acetazolamide—Headache—Conjugated Estrogens—prostate cancer	0.000221	0.00102	CcSEcCtD
Acetazolamide—Confusional state—Etoposide—prostate cancer	0.000221	0.00102	CcSEcCtD
Acetazolamide—Anaphylactic shock—Etoposide—prostate cancer	0.000219	0.00101	CcSEcCtD
Acetazolamide—Dysgeusia—Docetaxel—prostate cancer	0.000218	0.00101	CcSEcCtD
Acetazolamide—Ataxia—Doxorubicin—prostate cancer	0.000217	0.001	CcSEcCtD
Acetazolamide—Feeling abnormal—Mitoxantrone—prostate cancer	0.000217	0.000999	CcSEcCtD
Acetazolamide—Thrombocytopenia—Etoposide—prostate cancer	0.000214	0.000987	CcSEcCtD
Acetazolamide—Nausea—Goserelin—prostate cancer	0.000212	0.000975	CcSEcCtD
Acetazolamide—Dysgeusia—Capecitabine—prostate cancer	0.000211	0.000973	CcSEcCtD
Acetazolamide—Hypokalaemia—Doxorubicin—prostate cancer	0.00021	0.000968	CcSEcCtD
Acetazolamide—Nausea—Conjugated Estrogens—prostate cancer	0.00021	0.000965	CcSEcCtD
Acetazolamide—Urticaria—Mitoxantrone—prostate cancer	0.000209	0.000963	CcSEcCtD
Acetazolamide—Body temperature increased—Mitoxantrone—prostate cancer	0.000208	0.000958	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	0.000208	0.000958	CcSEcCtD
Acetazolamide—Flushing—Prednisone—prostate cancer	0.000205	0.000944	CcSEcCtD
Acetazolamide—Asthenia—Estradiol—prostate cancer	0.000203	0.000933	CcSEcCtD
Acetazolamide—Ill-defined disorder—Capecitabine—prostate cancer	0.0002	0.000922	CcSEcCtD
Acetazolamide—Leukopenia—Docetaxel—prostate cancer	0.0002	0.000919	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Epirubicin—prostate cancer	0.000197	0.000907	CcSEcCtD
Acetazolamide—Paraesthesia—Etoposide—prostate cancer	0.000197	0.000905	CcSEcCtD
Acetazolamide—Malaise—Capecitabine—prostate cancer	0.000195	0.000896	CcSEcCtD
Acetazolamide—Somnolence—Etoposide—prostate cancer	0.000195	0.000896	CcSEcCtD
Acetazolamide—Diarrhoea—Estradiol—prostate cancer	0.000193	0.00089	CcSEcCtD
Acetazolamide—Leukopenia—Capecitabine—prostate cancer	0.000193	0.00089	CcSEcCtD
Acetazolamide—Convulsion—Docetaxel—prostate cancer	0.000193	0.00089	CcSEcCtD
Acetazolamide—Drowsiness—Epirubicin—prostate cancer	0.000193	0.000886	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000191	0.000879	CcSEcCtD
Acetazolamide—Decreased appetite—Etoposide—prostate cancer	0.00019	0.000876	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Etoposide—prostate cancer	0.000189	0.00087	CcSEcCtD
Acetazolamide—Asthenia—Mitoxantrone—prostate cancer	0.000189	0.00087	CcSEcCtD
Acetazolamide—Fatigue—Etoposide—prostate cancer	0.000189	0.000869	CcSEcCtD
Acetazolamide—Dizziness—Estradiol—prostate cancer	0.000187	0.00086	CcSEcCtD
Acetazolamide—Haematuria—Epirubicin—prostate cancer	0.000184	0.000845	CcSEcCtD
Acetazolamide—Confusional state—Docetaxel—prostate cancer	0.000184	0.000845	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000182	0.000839	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Epirubicin—prostate cancer	0.000182	0.000838	CcSEcCtD
Acetazolamide—Anaphylactic shock—Docetaxel—prostate cancer	0.000182	0.000838	CcSEcCtD
Acetazolamide—Discomfort—Capecitabine—prostate cancer	0.000182	0.000836	CcSEcCtD
Acetazolamide—Feeling abnormal—Etoposide—prostate cancer	0.000181	0.000831	CcSEcCtD
Acetazolamide—Diarrhoea—Mitoxantrone—prostate cancer	0.00018	0.000829	CcSEcCtD
Acetazolamide—Vomiting—Estradiol—prostate cancer	0.00018	0.000827	CcSEcCtD
Acetazolamide—Agranulocytosis—Epirubicin—prostate cancer	0.00018	0.000827	CcSEcCtD
Acetazolamide—Shock—Docetaxel—prostate cancer	0.000179	0.000824	CcSEcCtD
Acetazolamide—Ill-defined disorder—Prednisone—prostate cancer	0.000178	0.000822	CcSEcCtD
Acetazolamide—Thrombocytopenia—Docetaxel—prostate cancer	0.000178	0.00082	CcSEcCtD
Acetazolamide—Drowsiness—Doxorubicin—prostate cancer	0.000178	0.00082	CcSEcCtD
Acetazolamide—Confusional state—Capecitabine—prostate cancer	0.000178	0.000818	CcSEcCtD
Acetazolamide—Headache—Estradiol—prostate cancer	0.000177	0.000815	CcSEcCtD
Acetazolamide—Agitation—Prednisone—prostate cancer	0.000177	0.000814	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000177	0.000813	CcSEcCtD
Acetazolamide—Urticaria—Etoposide—prostate cancer	0.000174	0.000801	CcSEcCtD
Acetazolamide—Malaise—Prednisone—prostate cancer	0.000173	0.000798	CcSEcCtD
Acetazolamide—Shock—Capecitabine—prostate cancer	0.000173	0.000798	CcSEcCtD
Acetazolamide—Body temperature increased—Etoposide—prostate cancer	0.000173	0.000797	CcSEcCtD
Acetazolamide—Thrombocytopenia—Capecitabine—prostate cancer	0.000173	0.000794	CcSEcCtD
Acetazolamide—Hypoaesthesia—Epirubicin—prostate cancer	0.000172	0.000791	CcSEcCtD
Acetazolamide—Haematuria—Doxorubicin—prostate cancer	0.00017	0.000782	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000168	0.000775	CcSEcCtD
Acetazolamide—Nausea—Estradiol—prostate cancer	0.000168	0.000773	CcSEcCtD
Acetazolamide—Vomiting—Mitoxantrone—prostate cancer	0.000167	0.000771	CcSEcCtD
Acetazolamide—Convulsion—Prednisone—prostate cancer	0.000167	0.000767	CcSEcCtD
Acetazolamide—Agranulocytosis—Doxorubicin—prostate cancer	0.000166	0.000765	CcSEcCtD
Acetazolamide—Headache—Mitoxantrone—prostate cancer	0.000165	0.000759	CcSEcCtD
Acetazolamide—Paraesthesia—Docetaxel—prostate cancer	0.000163	0.000752	CcSEcCtD
Acetazolamide—Erythema multiforme—Epirubicin—prostate cancer	0.000163	0.000752	CcSEcCtD
Acetazolamide—Somnolence—Docetaxel—prostate cancer	0.000162	0.000745	CcSEcCtD
Acetazolamide—Discomfort—Prednisone—prostate cancer	0.000162	0.000745	CcSEcCtD
Acetazolamide—Tinnitus—Epirubicin—prostate cancer	0.000161	0.000742	CcSEcCtD
Acetazolamide—Flushing—Epirubicin—prostate cancer	0.00016	0.000738	CcSEcCtD
Acetazolamide—Dyspepsia—Docetaxel—prostate cancer	0.00016	0.000738	CcSEcCtD
Acetazolamide—Hypoaesthesia—Doxorubicin—prostate cancer	0.000159	0.000732	CcSEcCtD
Acetazolamide—Paraesthesia—Capecitabine—prostate cancer	0.000158	0.000728	CcSEcCtD
Acetazolamide—Decreased appetite—Docetaxel—prostate cancer	0.000158	0.000728	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000157	0.000723	CcSEcCtD
Acetazolamide—Asthenia—Etoposide—prostate cancer	0.000157	0.000723	CcSEcCtD
Acetazolamide—Anaphylactic shock—Prednisone—prostate cancer	0.000157	0.000723	CcSEcCtD
Acetazolamide—Fatigue—Docetaxel—prostate cancer	0.000157	0.000722	CcSEcCtD
Acetazolamide—Nausea—Mitoxantrone—prostate cancer	0.000156	0.00072	CcSEcCtD
Acetazolamide—Dyspepsia—Capecitabine—prostate cancer	0.000155	0.000714	CcSEcCtD
Acetazolamide—Shock—Prednisone—prostate cancer	0.000154	0.000711	CcSEcCtD
Acetazolamide—Decreased appetite—Capecitabine—prostate cancer	0.000153	0.000705	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000152	0.0007	CcSEcCtD
Acetazolamide—Fatigue—Capecitabine—prostate cancer	0.000152	0.000699	CcSEcCtD
Acetazolamide—Erythema multiforme—Doxorubicin—prostate cancer	0.000151	0.000696	CcSEcCtD
Acetazolamide—Feeling abnormal—Docetaxel—prostate cancer	0.00015	0.00069	CcSEcCtD
Acetazolamide—Diarrhoea—Etoposide—prostate cancer	0.00015	0.00069	CcSEcCtD
Acetazolamide—Tinnitus—Doxorubicin—prostate cancer	0.000149	0.000686	CcSEcCtD
Acetazolamide—Flushing—Doxorubicin—prostate cancer	0.000148	0.000683	CcSEcCtD
Acetazolamide—Dysgeusia—Epirubicin—prostate cancer	0.000147	0.000678	CcSEcCtD
Acetazolamide—Feeling abnormal—Capecitabine—prostate cancer	0.000145	0.000669	CcSEcCtD
Acetazolamide—Dizziness—Etoposide—prostate cancer	0.000145	0.000667	CcSEcCtD
Acetazolamide—Body temperature increased—Docetaxel—prostate cancer	0.000144	0.000662	CcSEcCtD
Acetazolamide—Paraesthesia—Prednisone—prostate cancer	0.000141	0.000649	CcSEcCtD
Acetazolamide—Urticaria—Capecitabine—prostate cancer	0.00014	0.000644	CcSEcCtD
Acetazolamide—Ill-defined disorder—Epirubicin—prostate cancer	0.00014	0.000643	CcSEcCtD
Acetazolamide—Body temperature increased—Capecitabine—prostate cancer	0.000139	0.000641	CcSEcCtD
Acetazolamide—Vomiting—Etoposide—prostate cancer	0.000139	0.000641	CcSEcCtD
Acetazolamide—Agitation—Epirubicin—prostate cancer	0.000138	0.000636	CcSEcCtD
Acetazolamide—Dyspepsia—Prednisone—prostate cancer	0.000138	0.000636	CcSEcCtD
Acetazolamide—Headache—Etoposide—prostate cancer	0.000137	0.000632	CcSEcCtD
Acetazolamide—Decreased appetite—Prednisone—prostate cancer	0.000136	0.000628	CcSEcCtD
Acetazolamide—Dysgeusia—Doxorubicin—prostate cancer	0.000136	0.000627	CcSEcCtD
Acetazolamide—Malaise—Epirubicin—prostate cancer	0.000136	0.000624	CcSEcCtD
Acetazolamide—Fatigue—Prednisone—prostate cancer	0.000135	0.000623	CcSEcCtD
Acetazolamide—Leukopenia—Epirubicin—prostate cancer	0.000135	0.00062	CcSEcCtD
Acetazolamide—Asthenia—Docetaxel—prostate cancer	0.000131	0.000601	CcSEcCtD
Acetazolamide—Convulsion—Epirubicin—prostate cancer	0.00013	0.0006	CcSEcCtD
Acetazolamide—Nausea—Etoposide—prostate cancer	0.00013	0.000599	CcSEcCtD
Acetazolamide—Feeling abnormal—Prednisone—prostate cancer	0.000129	0.000595	CcSEcCtD
Acetazolamide—Ill-defined disorder—Doxorubicin—prostate cancer	0.000129	0.000594	CcSEcCtD
Acetazolamide—Agitation—Doxorubicin—prostate cancer	0.000128	0.000589	CcSEcCtD
Acetazolamide—Discomfort—Epirubicin—prostate cancer	0.000127	0.000582	CcSEcCtD
Acetazolamide—Asthenia—Capecitabine—prostate cancer	0.000126	0.000582	CcSEcCtD
Acetazolamide—Malaise—Doxorubicin—prostate cancer	0.000126	0.000578	CcSEcCtD
Acetazolamide—Urticaria—Prednisone—prostate cancer	0.000125	0.000574	CcSEcCtD
Acetazolamide—Leukopenia—Doxorubicin—prostate cancer	0.000125	0.000574	CcSEcCtD
Acetazolamide—Diarrhoea—Docetaxel—prostate cancer	0.000125	0.000573	CcSEcCtD
Acetazolamide—Body temperature increased—Prednisone—prostate cancer	0.000124	0.000571	CcSEcCtD
Acetazolamide—Confusional state—Epirubicin—prostate cancer	0.000124	0.00057	CcSEcCtD
Acetazolamide—Anaphylactic shock—Epirubicin—prostate cancer	0.000123	0.000565	CcSEcCtD
Acetazolamide—Shock—Epirubicin—prostate cancer	0.000121	0.000556	CcSEcCtD
Acetazolamide—Convulsion—Doxorubicin—prostate cancer	0.000121	0.000555	CcSEcCtD
Acetazolamide—Diarrhoea—Capecitabine—prostate cancer	0.000121	0.000555	CcSEcCtD
Acetazolamide—Dizziness—Docetaxel—prostate cancer	0.00012	0.000554	CcSEcCtD
Acetazolamide—Thrombocytopenia—Epirubicin—prostate cancer	0.00012	0.000553	CcSEcCtD
Acetazolamide—Discomfort—Doxorubicin—prostate cancer	0.000117	0.000539	CcSEcCtD
Acetazolamide—Dizziness—Capecitabine—prostate cancer	0.000117	0.000536	CcSEcCtD
Acetazolamide—Vomiting—Docetaxel—prostate cancer	0.000116	0.000533	CcSEcCtD
Acetazolamide—Confusional state—Doxorubicin—prostate cancer	0.000115	0.000527	CcSEcCtD
Acetazolamide—Headache—Docetaxel—prostate cancer	0.000114	0.000525	CcSEcCtD
Acetazolamide—Anaphylactic shock—Doxorubicin—prostate cancer	0.000114	0.000523	CcSEcCtD
Acetazolamide—Asthenia—Prednisone—prostate cancer	0.000113	0.000518	CcSEcCtD
Acetazolamide—Vomiting—Capecitabine—prostate cancer	0.000112	0.000516	CcSEcCtD
Acetazolamide—Shock—Doxorubicin—prostate cancer	0.000112	0.000514	CcSEcCtD
Acetazolamide—Thrombocytopenia—Doxorubicin—prostate cancer	0.000111	0.000512	CcSEcCtD
Acetazolamide—Headache—Capecitabine—prostate cancer	0.00011	0.000508	CcSEcCtD
Acetazolamide—Paraesthesia—Epirubicin—prostate cancer	0.00011	0.000507	CcSEcCtD
Acetazolamide—Somnolence—Epirubicin—prostate cancer	0.000109	0.000502	CcSEcCtD
Acetazolamide—Nausea—Docetaxel—prostate cancer	0.000108	0.000498	CcSEcCtD
Acetazolamide—Dyspepsia—Epirubicin—prostate cancer	0.000108	0.000497	CcSEcCtD
Acetazolamide—Diarrhoea—Prednisone—prostate cancer	0.000107	0.000494	CcSEcCtD
Acetazolamide—Decreased appetite—Epirubicin—prostate cancer	0.000107	0.000491	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000106	0.000488	CcSEcCtD
Acetazolamide—Fatigue—Epirubicin—prostate cancer	0.000106	0.000487	CcSEcCtD
Acetazolamide—Nausea—Capecitabine—prostate cancer	0.000105	0.000482	CcSEcCtD
Acetazolamide—Dizziness—Prednisone—prostate cancer	0.000104	0.000478	CcSEcCtD
Acetazolamide—Paraesthesia—Doxorubicin—prostate cancer	0.000102	0.00047	CcSEcCtD
Acetazolamide—Feeling abnormal—Epirubicin—prostate cancer	0.000101	0.000466	CcSEcCtD
Acetazolamide—Somnolence—Doxorubicin—prostate cancer	0.000101	0.000465	CcSEcCtD
Acetazolamide—Dyspepsia—Doxorubicin—prostate cancer	0.0001	0.00046	CcSEcCtD
Acetazolamide—Vomiting—Prednisone—prostate cancer	9.98e-05	0.000459	CcSEcCtD
Acetazolamide—Decreased appetite—Doxorubicin—prostate cancer	9.88e-05	0.000455	CcSEcCtD
Acetazolamide—Headache—Prednisone—prostate cancer	9.84e-05	0.000453	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Doxorubicin—prostate cancer	9.81e-05	0.000451	CcSEcCtD
Acetazolamide—Fatigue—Doxorubicin—prostate cancer	9.8e-05	0.000451	CcSEcCtD
Acetazolamide—Urticaria—Epirubicin—prostate cancer	9.76e-05	0.000449	CcSEcCtD
Acetazolamide—Body temperature increased—Epirubicin—prostate cancer	9.71e-05	0.000447	CcSEcCtD
Acetazolamide—Feeling abnormal—Doxorubicin—prostate cancer	9.36e-05	0.000431	CcSEcCtD
Acetazolamide—Nausea—Prednisone—prostate cancer	9.33e-05	0.000429	CcSEcCtD
Acetazolamide—Urticaria—Doxorubicin—prostate cancer	9.03e-05	0.000415	CcSEcCtD
Acetazolamide—Body temperature increased—Doxorubicin—prostate cancer	8.98e-05	0.000413	CcSEcCtD
Acetazolamide—Asthenia—Epirubicin—prostate cancer	8.81e-05	0.000405	CcSEcCtD
Acetazolamide—Diarrhoea—Epirubicin—prostate cancer	8.4e-05	0.000387	CcSEcCtD
Acetazolamide—Asthenia—Doxorubicin—prostate cancer	8.15e-05	0.000375	CcSEcCtD
Acetazolamide—Dizziness—Epirubicin—prostate cancer	8.12e-05	0.000374	CcSEcCtD
Acetazolamide—Vomiting—Epirubicin—prostate cancer	7.81e-05	0.000359	CcSEcCtD
Acetazolamide—Diarrhoea—Doxorubicin—prostate cancer	7.77e-05	0.000358	CcSEcCtD
Acetazolamide—Headache—Epirubicin—prostate cancer	7.69e-05	0.000354	CcSEcCtD
Acetazolamide—Dizziness—Doxorubicin—prostate cancer	7.51e-05	0.000346	CcSEcCtD
Acetazolamide—Nausea—Epirubicin—prostate cancer	7.29e-05	0.000336	CcSEcCtD
Acetazolamide—Vomiting—Doxorubicin—prostate cancer	7.22e-05	0.000332	CcSEcCtD
Acetazolamide—Headache—Doxorubicin—prostate cancer	7.12e-05	0.000328	CcSEcCtD
Acetazolamide—Nausea—Doxorubicin—prostate cancer	6.75e-05	0.000311	CcSEcCtD
Acetazolamide—CA5B—Metabolism—INS—prostate cancer	2.23e-05	0.000145	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—INS—prostate cancer	2.23e-05	0.000145	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP19A1—prostate cancer	2.22e-05	0.000145	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—NCOA1—prostate cancer	2.22e-05	0.000145	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP1A1—prostate cancer	2.22e-05	0.000144	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CD—prostate cancer	2.21e-05	0.000144	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CD—prostate cancer	2.21e-05	0.000144	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—LPL—prostate cancer	2.2e-05	0.000143	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ERCC2—prostate cancer	2.2e-05	0.000143	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	2.19e-05	0.000142	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CREBBP—prostate cancer	2.18e-05	0.000142	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CREBBP—prostate cancer	2.18e-05	0.000142	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CG—prostate cancer	2.18e-05	0.000142	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—TYMS—prostate cancer	2.18e-05	0.000142	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PIK3CA—prostate cancer	2.16e-05	0.000141	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	2.16e-05	0.00014	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSTM1—prostate cancer	2.15e-05	0.00014	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—RXRA—prostate cancer	2.15e-05	0.00014	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—NOS3—prostate cancer	2.15e-05	0.00014	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP1A1—prostate cancer	2.13e-05	0.000138	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—RXRA—prostate cancer	2.11e-05	0.000137	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—LPL—prostate cancer	2.11e-05	0.000137	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ERCC2—prostate cancer	2.11e-05	0.000137	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	2.1e-05	0.000137	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—NOS3—prostate cancer	2.09e-05	0.000136	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—NOS3—prostate cancer	2.09e-05	0.000136	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—MTHFR—prostate cancer	2.07e-05	0.000135	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CD—prostate cancer	2.07e-05	0.000135	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CD—prostate cancer	2.07e-05	0.000135	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—COMT—prostate cancer	2.07e-05	0.000135	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—INS—prostate cancer	2.06e-05	0.000134	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTP1—prostate cancer	2.06e-05	0.000134	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP1A1—prostate cancer	2.04e-05	0.000133	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—COMT—prostate cancer	2.03e-05	0.000132	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PPARA—prostate cancer	2.03e-05	0.000132	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTP1—prostate cancer	2.02e-05	0.000132	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ITPR1—prostate cancer	2.02e-05	0.000132	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ERCC2—prostate cancer	2.02e-05	0.000132	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CREBBP—prostate cancer	2.02e-05	0.000131	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	2.01e-05	0.000131	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	2e-05	0.00013	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—MTHFR—prostate cancer	1.98e-05	0.000129	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CB—prostate cancer	1.98e-05	0.000129	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PTGS2—prostate cancer	1.96e-05	0.000128	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—NOS3—prostate cancer	1.95e-05	0.000127	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—NOS3—prostate cancer	1.95e-05	0.000127	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PPARA—prostate cancer	1.94e-05	0.000127	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CB—prostate cancer	1.93e-05	0.000126	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CB—prostate cancer	1.93e-05	0.000126	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CD—prostate cancer	1.91e-05	0.000125	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—TYMS—prostate cancer	1.91e-05	0.000124	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTGS2—prostate cancer	1.91e-05	0.000124	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTGS2—prostate cancer	1.91e-05	0.000124	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CAV1—prostate cancer	1.91e-05	0.000124	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—MTHFR—prostate cancer	1.9e-05	0.000124	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTM1—prostate cancer	1.89e-05	0.000123	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PIK3CA—prostate cancer	1.87e-05	0.000122	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PPARA—prostate cancer	1.86e-05	0.000121	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTM1—prostate cancer	1.86e-05	0.000121	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—LPL—prostate cancer	1.86e-05	0.000121	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	1.84e-05	0.000119	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CAV1—prostate cancer	1.83e-05	0.000119	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—NOS3—prostate cancer	1.81e-05	0.000118	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CB—prostate cancer	1.8e-05	0.000117	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CB—prostate cancer	1.8e-05	0.000117	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP1A1—prostate cancer	1.79e-05	0.000117	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTGS2—prostate cancer	1.79e-05	0.000116	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTGS2—prostate cancer	1.79e-05	0.000116	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ERCC2—prostate cancer	1.78e-05	0.000116	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—AKT1—prostate cancer	1.77e-05	0.000115	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	1.76e-05	0.000115	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CAV1—prostate cancer	1.75e-05	0.000114	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HAO1—prostate cancer	1.74e-05	0.000113	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	1.74e-05	0.000113	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CG—prostate cancer	1.74e-05	0.000113	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PTEN—prostate cancer	1.71e-05	0.000111	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—MTHFR—prostate cancer	1.67e-05	0.000109	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CB—prostate cancer	1.67e-05	0.000109	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTEN—prostate cancer	1.67e-05	0.000109	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTEN—prostate cancer	1.67e-05	0.000109	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.67e-05	0.000108	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CG—prostate cancer	1.67e-05	0.000108	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTGS2—prostate cancer	1.65e-05	0.000108	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—INS—prostate cancer	1.64e-05	0.000107	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PPARA—prostate cancer	1.64e-05	0.000107	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—EP300—prostate cancer	1.63e-05	0.000106	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CREBBP—prostate cancer	1.61e-05	0.000105	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CG—prostate cancer	1.6e-05	0.000104	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—EP300—prostate cancer	1.59e-05	0.000104	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—EP300—prostate cancer	1.59e-05	0.000104	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—INS—prostate cancer	1.58e-05	0.000103	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTEN—prostate cancer	1.56e-05	0.000101	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTEN—prostate cancer	1.56e-05	0.000101	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CREBBP—prostate cancer	1.54e-05	0.0001	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CAV1—prostate cancer	1.54e-05	0.0001	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—AKT1—prostate cancer	1.53e-05	9.96e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CD—prostate cancer	1.53e-05	9.94e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—INS—prostate cancer	1.51e-05	9.84e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—EP300—prostate cancer	1.48e-05	9.66e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—EP300—prostate cancer	1.48e-05	9.66e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CREBBP—prostate cancer	1.48e-05	9.64e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CD—prostate cancer	1.46e-05	9.53e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTEN—prostate cancer	1.44e-05	9.39e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—NOS3—prostate cancer	1.44e-05	9.39e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CBR1—prostate cancer	1.42e-05	9.24e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TST—prostate cancer	1.42e-05	9.24e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CSAD—prostate cancer	1.42e-05	9.24e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PSAT1—prostate cancer	1.42e-05	9.24e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GRHL1—prostate cancer	1.42e-05	9.24e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ADI1—prostate cancer	1.42e-05	9.24e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CG—prostate cancer	1.4e-05	9.14e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CD—prostate cancer	1.4e-05	9.14e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—NOS3—prostate cancer	1.38e-05	9e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—EP300—prostate cancer	1.38e-05	8.95e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CB—prostate cancer	1.33e-05	8.66e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—INS—prostate cancer	1.33e-05	8.65e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—NOS3—prostate cancer	1.33e-05	8.63e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GRHPR—prostate cancer	1.32e-05	8.59e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CKMT2—prostate cancer	1.32e-05	8.59e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.32e-05	8.59e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.32e-05	8.59e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTGS2—prostate cancer	1.32e-05	8.58e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CREBBP—prostate cancer	1.3e-05	8.47e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CB—prostate cancer	1.28e-05	8.31e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTGS2—prostate cancer	1.26e-05	8.23e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AOX1—prostate cancer	1.24e-05	8.07e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NAGLU—prostate cancer	1.24e-05	8.07e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTM3—prostate cancer	1.24e-05	8.07e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.24e-05	8.07e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PGAM2—prostate cancer	1.24e-05	8.07e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.24e-05	8.07e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—RFK—prostate cancer	1.24e-05	8.07e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CD—prostate cancer	1.23e-05	8.03e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CB—prostate cancer	1.22e-05	7.96e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTGS2—prostate cancer	1.21e-05	7.89e-05	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CA—prostate cancer	1.21e-05	7.86e-05	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CA—prostate cancer	1.18e-05	7.66e-05	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CA—prostate cancer	1.18e-05	7.66e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AMACR—prostate cancer	1.18e-05	7.65e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.18e-05	7.65e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—DEGS1—prostate cancer	1.18e-05	7.65e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.18e-05	7.65e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NAT1—prostate cancer	1.18e-05	7.65e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—NOS3—prostate cancer	1.17e-05	7.58e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTEN—prostate cancer	1.15e-05	7.49e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.12e-05	7.3e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTEN—prostate cancer	1.1e-05	7.18e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CA—prostate cancer	1.1e-05	7.15e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CA—prostate cancer	1.1e-05	7.15e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—EP300—prostate cancer	1.1e-05	7.14e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CB—prostate cancer	1.08e-05	7e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTGS2—prostate cancer	1.07e-05	6.94e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTEN—prostate cancer	1.06e-05	6.88e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—EP300—prostate cancer	1.05e-05	6.84e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CA—prostate cancer	1.02e-05	6.62e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—EP300—prostate cancer	1.01e-05	6.56e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HPGD—prostate cancer	1e-05	6.51e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—B4GALT4—prostate cancer	1e-05	6.51e-05	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AKT1—prostate cancer	9.86e-06	6.42e-05	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AKT1—prostate cancer	9.61e-06	6.26e-05	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AKT1—prostate cancer	9.61e-06	6.26e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TNFRSF21—prostate cancer	9.4e-06	6.12e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTEN—prostate cancer	9.29e-06	6.05e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP7B1—prostate cancer	9.15e-06	5.95e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—MTAP—prostate cancer	9.15e-06	5.95e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AKT1—prostate cancer	8.97e-06	5.84e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AKT1—prostate cancer	8.97e-06	5.84e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SULT1E1—prostate cancer	8.91e-06	5.8e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SRD5A1—prostate cancer	8.91e-06	5.8e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—EP300—prostate cancer	8.86e-06	5.77e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ACSL4—prostate cancer	8.5e-06	5.53e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HSD17B3—prostate cancer	8.5e-06	5.53e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AKT1—prostate cancer	8.31e-06	5.41e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—UMPS—prostate cancer	8.15e-06	5.31e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ARG2—prostate cancer	8.15e-06	5.31e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PHGDH—prostate cancer	8.15e-06	5.31e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CA—prostate cancer	8.11e-06	5.28e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—LDHB—prostate cancer	7.99e-06	5.2e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP3A5—prostate cancer	7.85e-06	5.11e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CA—prostate cancer	7.78e-06	5.06e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PDHA1—prostate cancer	7.58e-06	4.93e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—UCP3—prostate cancer	7.58e-06	4.93e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TCN2—prostate cancer	7.58e-06	4.93e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTA3—prostate cancer	7.58e-06	4.93e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CA—prostate cancer	7.46e-06	4.85e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HSD3B1—prostate cancer	7.23e-06	4.71e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC22A3—prostate cancer	7.23e-06	4.71e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TBXAS1—prostate cancer	6.93e-06	4.51e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTA4—prostate cancer	6.93e-06	4.51e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTA2—prostate cancer	6.75e-06	4.4e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SULT1A1—prostate cancer	6.67e-06	4.34e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ABCG5—prostate cancer	6.67e-06	4.34e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AKT1—prostate cancer	6.63e-06	4.31e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CA—prostate cancer	6.56e-06	4.27e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTA1—prostate cancer	6.52e-06	4.24e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HSD3B2—prostate cancer	6.44e-06	4.19e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NAT2—prostate cancer	6.44e-06	4.19e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTO1—prostate cancer	6.44e-06	4.19e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AKT1—prostate cancer	6.35e-06	4.14e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PLCB2—prostate cancer	6.18e-06	4.02e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP2C18—prostate cancer	6.18e-06	4.02e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—LRP2—prostate cancer	6.18e-06	4.02e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AKT1—prostate cancer	6.09e-06	3.97e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—P4HB—prostate cancer	6.06e-06	3.94e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC22A1—prostate cancer	5.89e-06	3.84e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SULT2A1—prostate cancer	5.74e-06	3.74e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—MED12—prostate cancer	5.65e-06	3.68e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GNG5—prostate cancer	5.61e-06	3.65e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NCOA3—prostate cancer	5.4e-06	3.51e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AKT1—prostate cancer	5.36e-06	3.49e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HPGDS—prostate cancer	5.15e-06	3.35e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP2C19—prostate cancer	5.12e-06	3.33e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTT1—prostate cancer	5e-06	3.25e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ACHE—prostate cancer	5e-06	3.25e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.94e-06	3.21e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.8e-06	3.13e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PRKACB—prostate cancer	4.78e-06	3.11e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.73e-06	3.08e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NCOA2—prostate cancer	4.51e-06	2.93e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC5A5—prostate cancer	4.3e-06	2.8e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP2E1—prostate cancer	4.2e-06	2.73e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NQO1—prostate cancer	4.15e-06	2.7e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TH—prostate cancer	4.09e-06	2.66e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.98e-06	2.59e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GGT1—prostate cancer	3.86e-06	2.51e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NCOA1—prostate cancer	3.8e-06	2.47e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.74e-06	2.44e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—RXRA—prostate cancer	3.61e-06	2.35e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—COMT—prostate cancer	3.48e-06	2.26e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTP1—prostate cancer	3.46e-06	2.25e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ITPR1—prostate cancer	3.41e-06	2.22e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TYMS—prostate cancer	3.22e-06	2.1e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTM1—prostate cancer	3.18e-06	2.07e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—LPL—prostate cancer	3.12e-06	2.03e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.02e-06	1.96e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ERCC2—prostate cancer	2.99e-06	1.95e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—MTHFR—prostate cancer	2.81e-06	1.83e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPARA—prostate cancer	2.76e-06	1.8e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CAV1—prostate cancer	2.59e-06	1.69e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.36e-06	1.54e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—INS—prostate cancer	2.24e-06	1.46e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CREBBP—prostate cancer	2.19e-06	1.43e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.08e-06	1.35e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NOS3—prostate cancer	1.96e-06	1.28e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.81e-06	1.18e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTGS2—prostate cancer	1.79e-06	1.17e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTEN—prostate cancer	1.56e-06	1.02e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—EP300—prostate cancer	1.49e-06	9.71e-06	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.1e-06	7.18e-06	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AKT1—prostate cancer	9.02e-07	5.87e-06	CbGpPWpGaD
